DAWN – Day One Biopharmaceuticals, Inc.
Day One Biopharmaceuticals, IncDAWN
$6.47Name : Day One Biopharmaceuticals, Inc
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $655,812,096.00
EPSttm : -0.65
Day One Biopharmaceuticals, Inc
$6.47
0.15%$0.01Float Short %
16.89
Margin Of Safety %
Put/Call OI Ratio
0.27
EPS Next Q Diff
0.02
EPS Last/This Y
-0.34
EPS This/Next Y
0.5
Price
6.47
Target Price
28
Analyst Recom
1.22
Performance Q
-21
Relative Volume
3.38
Beta
-1.28
Ticker: DAWN
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-06-02 | DAWN | 7.01 | 0.26 | 0.00 | 5186 |
| 2025-06-03 | DAWN | 6.96 | 0.26 | 0.10 | 5197 |
| 2025-06-04 | DAWN | 6.94 | 0.26 | 0.40 | 5318 |
| 2025-06-05 | DAWN | 6.94 | 0.26 | 0.04 | 5330 |
| 2025-06-06 | DAWN | 7.18 | 0.26 | 0.00 | 5383 |
| 2025-06-09 | DAWN | 7.09 | 0.25 | 0.00 | 5524 |
| 2025-06-10 | DAWN | 6.98 | 0.25 | 0.00 | 5539 |
| 2025-06-11 | DAWN | 6.75 | 0.25 | 0.10 | 5545 |
| 2025-06-12 | DAWN | 6.73 | 0.24 | 0.08 | 5577 |
| 2025-06-13 | DAWN | 6.67 | 0.25 | 0.00 | 5599 |
| 2025-06-16 | DAWN | 6.64 | 0.25 | 0.21 | 5604 |
| 2025-06-17 | DAWN | 6.5 | 0.25 | 0.30 | 5607 |
| 2025-06-18 | DAWN | 6.41 | 0.25 | 0.14 | 5620 |
| 2025-06-20 | DAWN | 6.32 | 0.24 | 0.04 | 5638 |
| 2025-06-23 | DAWN | 6.52 | 0.30 | 0.04 | 4537 |
| 2025-06-24 | DAWN | 6.47 | 0.30 | 0.57 | 4554 |
| 2025-06-25 | DAWN | 6.45 | 0.30 | 0.22 | 4557 |
| 2025-06-26 | DAWN | 6.49 | 0.29 | 0.00 | 4584 |
| 2025-06-27 | DAWN | 6.47 | 0.27 | 0.00 | 4533 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-06-02 | DAWN | 7.01 | -591.0 | - | -1.36 |
| 2025-06-03 | DAWN | 6.98 | -591.0 | - | -1.36 |
| 2025-06-04 | DAWN | 6.93 | -591.0 | - | -1.36 |
| 2025-06-05 | DAWN | 6.95 | -591.0 | - | -1.36 |
| 2025-06-06 | DAWN | 7.17 | -591.0 | - | -1.36 |
| 2025-06-09 | DAWN | 7.08 | -591.0 | - | -1.36 |
| 2025-06-10 | DAWN | 6.97 | -591.0 | - | -1.36 |
| 2025-06-11 | DAWN | 6.73 | -591.0 | - | -1.36 |
| 2025-06-12 | DAWN | 6.69 | -591.0 | - | -1.36 |
| 2025-06-13 | DAWN | 6.66 | -591.0 | - | -1.36 |
| 2025-06-16 | DAWN | 6.63 | -591.0 | - | -1.36 |
| 2025-06-17 | DAWN | 6.51 | -591.0 | - | -1.36 |
| 2025-06-18 | DAWN | 6.41 | -591.0 | - | -1.36 |
| 2025-06-20 | DAWN | 6.32 | -591.0 | - | -1.36 |
| 2025-06-23 | DAWN | 6.50 | -591.0 | - | -1.36 |
| 2025-06-24 | DAWN | 6.47 | -591.0 | - | -1.36 |
| 2025-06-25 | DAWN | 6.45 | -591.0 | - | -1.36 |
| 2025-06-26 | DAWN | 6.48 | -591.0 | - | -1.36 |
| 2025-06-27 | DAWN | 6.47 | -591.0 | - | -1.36 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-06-02 | DAWN | -0.29 | 0.70 | 24.68 |
| 2025-06-03 | DAWN | -0.29 | 0.70 | 24.68 |
| 2025-06-04 | DAWN | -0.29 | 0.70 | 24.68 |
| 2025-06-05 | DAWN | -0.29 | 0.70 | 24.68 |
| 2025-06-06 | DAWN | -0.29 | 0.70 | 24.68 |
| 2025-06-09 | DAWN | -0.29 | 0.46 | 24.68 |
| 2025-06-10 | DAWN | -0.29 | 0.46 | 24.68 |
| 2025-06-11 | DAWN | -0.29 | 0.46 | 24.85 |
| 2025-06-12 | DAWN | -0.29 | 0.46 | 24.85 |
| 2025-06-13 | DAWN | -0.18 | 0.46 | 24.85 |
| 2025-06-16 | DAWN | -0.18 | 0.46 | 24.85 |
| 2025-06-17 | DAWN | -0.18 | 0.46 | 24.85 |
| 2025-06-18 | DAWN | -0.18 | 0.46 | 24.85 |
| 2025-06-20 | DAWN | -0.18 | 0.46 | 24.85 |
| 2025-06-23 | DAWN | -0.18 | 0.45 | 24.85 |
| 2025-06-24 | DAWN | -0.18 | 0.45 | 24.85 |
| 2025-06-25 | DAWN | -0.18 | 0.45 | 24.85 |
| 2025-06-26 | DAWN | -0.18 | 0.45 | 16.89 |
| 2025-06-27 | DAWN | -0.18 | 0.45 | 16.89 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.35
Avg. EPS Est. Current Quarter
-0.35
Avg. EPS Est. Next Quarter
-0.33
Insider Transactions
-0.18
Institutional Transactions
0.45
Beta
-1.28
Average Sales Estimate Current Quarter
35
Average Sales Estimate Next Quarter
40
Fair Value
Quality Score
45
Growth Score
25
Sentiment Score
40
Actual DrawDown %
77.5
Max Drawdown 5-Year %
Target Price
28
P/E
Forward P/E
PEG
P/S
4.05
P/B
1.37
P/Free Cash Flow
EPS
-0.67
Average EPS Est. Cur. Y
-1.36
EPS Next Y. (Est.)
-0.86
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-42.66
Relative Volume
3.38
Return on Equity vs Sector %
-38.3
Return on Equity vs Industry %
-20.4
EPS 1 7Days Diff
0.3
EPS 1 30Days Diff
0.06
EBIT Estimation
Day One Biopharmaceuticals, IncSector: Healthcare
Industry: Biotechnology
Employees: 181
Day One Biopharmaceuticals, Inc., a commercial-stage company, focused on advancing class medicines for childhood and adult diseases with equal intensity in the United States. The company's lead product candidate is tovorafenib, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed or refractory low-grade glioma; and Ipsen, a frontline raf-altered pLGG which is in Phase III clinical trial stage. It also developing DAY301, which is in phase I clinical trial for adult and pediatric cancers; and VRK1 Inhibitor which is in pre-clinical stage for adult and pediatric cancers. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Brisbane, California.
stock quote shares DAWN – Day One Biopharmaceuticals, Inc. Stock Price stock today
news today DAWN – Day One Biopharmaceuticals, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch DAWN – Day One Biopharmaceuticals, Inc. yahoo finance google finance
stock history DAWN – Day One Biopharmaceuticals, Inc. invest stock market
stock prices DAWN premarket after hours
ticker DAWN fair value insiders trading